617.373.3744 • l.bishop@northeastern.edu

HSE Venture QSM Diagnostics Awarded Competitive Grant from the National Science Foundation

HSE Venture QSM Diagnostics Awarded Competitive Grant from the National Science Foundation

Small Business Innovation Research Program Provides Seed Funding for R&D

Boston. MA, Jan. 24. 2018 – QSM Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development (R&D) work developing a diagnostic panel of tests to detect Gramnegative bacteria that cause urinary tract infections (UTIs).

This research grant will allow QSM Diagnostics to develop a point-of-care sensing platform for identification and quantification of Escherichia coli, Proteus mirabilis, Klebsiella pneumonia and Pseudomonas aerginosa bacteria in urine within 2 minutes of sample collection. This approach detects quorum sensing molecules produced at a rate of 10,000 molecules per hour thereby improving the limit of detection by approximately 4 orders of magnitude. The technology works directly in complex fluids without any reagent addition or separation steps.

“The National Science Foundation supports small businesses with the most innovative, cutting edge ideas that have the potential to become great commercial successes and make huge societal impacts,” said Barry  Johnson, Director of the NSF’s Division of Industrial Innovation and Partnerships. “We hope that this seed funding will spark solutions to some of the most important challenges of our time across all areas of science and technology.”

“This is an important milestone for QSM diagnostics. This grant will allow QSM Diagnostics to develop an easy to use, point of care, test to identify the source of an infection in seconds, allowing the caregiver to prescribe a targeted treatment during the office visit.” Said Dr. Ed Goluch, Founder and President of QSM Diagnostics.

Once a small business is awarded a Phase I SBIR/STTR grant (up to $225,000), it becomes eligible to apply for a Phase II grant (up to $750,000). Small businesses with Phase II grants are eligible to receive up to $500,000 in additional matching funds with qualifying third-party investment or sales.

NSF accepts Phase I proposals from small businesses twice annually in June and December. Small businesses with innovative science and technology solutions, and commercial potential are encouraged to apply. All proposals submitted to the NSF SBIR/STTR program undergo a rigorous merit-based review process.

About QSM Diagnostics: QSM Diagnostics, is an early stage medical diagnostics company residing at the Agility Labs incubator in the South End of Boston (http://www.agilitylabs.org/ ) developing products to help diagnose bacterial infections and to reduce the proliferation of treatment resistant bacteria.

To learn more about QSM Diagnostics, Inc. please contact Phil Devlin devlin@qsmdiagnostics.com.

About the National Science Foundation’s Small Business Programs: The National Science Foundation (NSF) awards roughly $200 million annually to startups and small businesses through the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) program, transforming scientific discovery into products and services with commercial and societal impact. The non-dilutive grants support research and development (R&D) across almost all areas of science and technology helping companies de-risk technology for commercial success. The NSF is an independent federal agency with a budget of about $7 billion that supports fundamental research and education across all fields of science and engineering.

To learn more about the NSF SBIR/STTR program, visit: www.nsf.gov/SBIR.



  1. Avatar
    Remote Wipe 2 years ago

    Is Phil and Northeastern graduate or are there NU students working on this effort?

    • Avatar
      Christine Cyphers 2 years ago

      Phil is an alumnus of Northeastern University.

Leave a reply

Your email address will not be published. Required fields are marked *